Report cover image

Global Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 196 Pages
SKU # APRC20355926

Description

Summary

According to APO Research, The global Valsartan market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valsartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Valsartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Valsartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Valsartan is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Valsartan include Alembic Pharmaceuticals, Amneal Pharmaceuticals, Aurobindo Pharma, HETERO, Huaren Pharmaceutical, Jubilant Pharma, LG Life Sciences, Lupin and Macleods Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valsartan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Valsartan, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valsartan sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Valsartan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Valsartan sales, projected growth trends, production technology, application and end-user industry.

Valsartan Segment by Company

Alembic Pharmaceuticals
Amneal Pharmaceuticals
Aurobindo Pharma
HETERO
Huaren Pharmaceutical
Jubilant Pharma
LG Life Sciences
Lupin
Macleods Pharmaceuticals
Square Pharmaceuticals
Torrent Pharmaceuticals
Unichem Laboratories
Mylan
Novartis
Sun Pharmaceutical
Teva
Zhejiang Huahai Pharmaceutical
Valsartan Segment by Type

80 mg Tablets
40 mg Tablets
320 mg Tablets
160 mg Tablets
Valsartan Segment by Application

Heart Failure
Heart Attack
Hypertension
Valsartan Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Valsartan market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Valsartan Market Size, 2020 VS 2024 VS 2031
1.3 Global Valsartan Market Size Estimates and Forecasts (2020-2031)
1.4 Global Valsartan Sales Estimates and Forecasts (2020-2031)
1.5 Global Valsartan Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Valsartan Market Dynamics
2.1 Valsartan Industry Trends
2.2 Valsartan Industry Drivers
2.3 Valsartan Industry Opportunities and Challenges
2.4 Valsartan Industry Restraints
3 Valsartan Market by Manufacturers
3.1 Global Valsartan Revenue by Manufacturers (2020-2025)
3.2 Global Valsartan Sales by Manufacturers (2020-2025)
3.3 Global Valsartan Average Sales Price by Manufacturers (2020-2025)
3.4 Global Valsartan Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Valsartan Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Valsartan Manufacturers, Product Type & Application
3.7 Global Valsartan Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Valsartan Market CR5 and HHI
3.8.2 Global Top 5 and 10 Valsartan Players Market Share by Revenue in 2024
3.8.3 2024 Valsartan Tier 1, Tier 2, and Tier 3
4 Valsartan Market by Type
4.1 Valsartan Type Introduction
4.1.1 80 mg Tablets
4.1.2 40 mg Tablets
4.1.3 320 mg Tablets
4.1.4 160 mg Tablets
4.2 Global Valsartan Sales by Type
4.2.1 Global Valsartan Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Valsartan Sales by Type (2020-2031)
4.2.3 Global Valsartan Sales Market Share by Type (2020-2031)
4.3 Global Valsartan Revenue by Type
4.3.1 Global Valsartan Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Valsartan Revenue by Type (2020-2031)
4.3.3 Global Valsartan Revenue Market Share by Type (2020-2031)
5 Valsartan Market by Application
5.1 Valsartan Application Introduction
5.1.1 Heart Failure
5.1.2 Heart Attack
5.1.3 Hypertension
5.2 Global Valsartan Sales by Application
5.2.1 Global Valsartan Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Valsartan Sales by Application (2020-2031)
5.2.3 Global Valsartan Sales Market Share by Application (2020-2031)
5.3 Global Valsartan Revenue by Application
5.3.1 Global Valsartan Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Valsartan Revenue by Application (2020-2031)
5.3.3 Global Valsartan Revenue Market Share by Application (2020-2031)
6 Global Valsartan Sales by Region
6.1 Global Valsartan Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Valsartan Sales by Region (2020-2031)
6.2.1 Global Valsartan Sales by Region (2020-2025)
6.2.2 Global Valsartan Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Valsartan Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Valsartan Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Valsartan Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Valsartan Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Valsartan Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Valsartan Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Valsartan Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Valsartan Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Valsartan Revenue by Region
7.1 Global Valsartan Revenue by Region
7.1.1 Global Valsartan Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Valsartan Revenue by Region (2020-2025)
7.1.3 Global Valsartan Revenue by Region (2026-2031)
7.1.4 Global Valsartan Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Valsartan Revenue (2020-2031)
7.2.2 North America Valsartan Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Valsartan Revenue (2020-2031)
7.3.2 Europe Valsartan Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Valsartan Revenue (2020-2031)
7.4.2 Asia-Pacific Valsartan Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Valsartan Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Valsartan Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Alembic Pharmaceuticals
8.1.1 Alembic Pharmaceuticals Comapny Information
8.1.2 Alembic Pharmaceuticals Business Overview
8.1.3 Alembic Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Alembic Pharmaceuticals Valsartan Product Portfolio
8.1.5 Alembic Pharmaceuticals Recent Developments
8.2 Amneal Pharmaceuticals
8.2.1 Amneal Pharmaceuticals Comapny Information
8.2.2 Amneal Pharmaceuticals Business Overview
8.2.3 Amneal Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Amneal Pharmaceuticals Valsartan Product Portfolio
8.2.5 Amneal Pharmaceuticals Recent Developments
8.3 Aurobindo Pharma
8.3.1 Aurobindo Pharma Comapny Information
8.3.2 Aurobindo Pharma Business Overview
8.3.3 Aurobindo Pharma Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Aurobindo Pharma Valsartan Product Portfolio
8.3.5 Aurobindo Pharma Recent Developments
8.4 HETERO
8.4.1 HETERO Comapny Information
8.4.2 HETERO Business Overview
8.4.3 HETERO Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 HETERO Valsartan Product Portfolio
8.4.5 HETERO Recent Developments
8.5 Huaren Pharmaceutical
8.5.1 Huaren Pharmaceutical Comapny Information
8.5.2 Huaren Pharmaceutical Business Overview
8.5.3 Huaren Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Huaren Pharmaceutical Valsartan Product Portfolio
8.5.5 Huaren Pharmaceutical Recent Developments
8.6 Jubilant Pharma
8.6.1 Jubilant Pharma Comapny Information
8.6.2 Jubilant Pharma Business Overview
8.6.3 Jubilant Pharma Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Jubilant Pharma Valsartan Product Portfolio
8.6.5 Jubilant Pharma Recent Developments
8.7 LG Life Sciences
8.7.1 LG Life Sciences Comapny Information
8.7.2 LG Life Sciences Business Overview
8.7.3 LG Life Sciences Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 LG Life Sciences Valsartan Product Portfolio
8.7.5 LG Life Sciences Recent Developments
8.8 Lupin
8.8.1 Lupin Comapny Information
8.8.2 Lupin Business Overview
8.8.3 Lupin Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Lupin Valsartan Product Portfolio
8.8.5 Lupin Recent Developments
8.9 Macleods Pharmaceuticals
8.9.1 Macleods Pharmaceuticals Comapny Information
8.9.2 Macleods Pharmaceuticals Business Overview
8.9.3 Macleods Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Macleods Pharmaceuticals Valsartan Product Portfolio
8.9.5 Macleods Pharmaceuticals Recent Developments
8.10 Square Pharmaceuticals
8.10.1 Square Pharmaceuticals Comapny Information
8.10.2 Square Pharmaceuticals Business Overview
8.10.3 Square Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Square Pharmaceuticals Valsartan Product Portfolio
8.10.5 Square Pharmaceuticals Recent Developments
8.11 Torrent Pharmaceuticals
8.11.1 Torrent Pharmaceuticals Comapny Information
8.11.2 Torrent Pharmaceuticals Business Overview
8.11.3 Torrent Pharmaceuticals Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Torrent Pharmaceuticals Valsartan Product Portfolio
8.11.5 Torrent Pharmaceuticals Recent Developments
8.12 Unichem Laboratories
8.12.1 Unichem Laboratories Comapny Information
8.12.2 Unichem Laboratories Business Overview
8.12.3 Unichem Laboratories Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Unichem Laboratories Valsartan Product Portfolio
8.12.5 Unichem Laboratories Recent Developments
8.13 Mylan
8.13.1 Mylan Comapny Information
8.13.2 Mylan Business Overview
8.13.3 Mylan Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Mylan Valsartan Product Portfolio
8.13.5 Mylan Recent Developments
8.14 Novartis
8.14.1 Novartis Comapny Information
8.14.2 Novartis Business Overview
8.14.3 Novartis Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Novartis Valsartan Product Portfolio
8.14.5 Novartis Recent Developments
8.15 Sun Pharmaceutical
8.15.1 Sun Pharmaceutical Comapny Information
8.15.2 Sun Pharmaceutical Business Overview
8.15.3 Sun Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Sun Pharmaceutical Valsartan Product Portfolio
8.15.5 Sun Pharmaceutical Recent Developments
8.16 Teva
8.16.1 Teva Comapny Information
8.16.2 Teva Business Overview
8.16.3 Teva Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Teva Valsartan Product Portfolio
8.16.5 Teva Recent Developments
8.17 Zhejiang Huahai Pharmaceutical
8.17.1 Zhejiang Huahai Pharmaceutical Comapny Information
8.17.2 Zhejiang Huahai Pharmaceutical Business Overview
8.17.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
8.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Valsartan Value Chain Analysis
9.1.1 Valsartan Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Valsartan Production Mode & Process
9.2 Valsartan Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Valsartan Distributors
9.2.3 Valsartan Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.